CXA-10 Study in Subjects With Pulmonary Arterial Hypertension
NCT04053543
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
33
Enrollment
INDUSTRY
Sponsor class
Stopped
LOE
Conditions
PAH
Interventions
DRUG:
CXA-10
Sponsor
Complexa, Inc.
Collaborators
[object Object]
[object Object]
[object Object]